Another Win for SGLT2 Inhibitors in Chronic Kidney Disease 만성 신장 질환에서 SGLT2 억제제의 또 다른 승리

posted in: Uncategorized | 0

Another Win for SGLT2 Inhibitors in Chronic Kidney Disease Authors: David E. Leaf, M.D. https://orcid.org/0000-0001-7875-090X, and Nisha Bansal, M.D.Author Info & Affiliations Published February 19, 2025 N Engl J Med 2025;392:822-823 DOI: 10.1056/NEJMe2500233 VOL. 392 NO. 8 Copyright © 2025 Abstract Chronic kidney disease affects 14% of the U.S. population 1 and is … Continued

The oldest hospital in Connecticut opened almost 200 years ago. Here’s where it is Yale Hospital 코네티컷에서 가장 오래된 병원 Yale 은 거의 200년 전에 문을 열었습니다. 이곳이 바로 Yale 병원이 있는 곳입니다.

posted in: Uncategorized | 0

The oldest hospital in Connecticut opened almost 200 years ago. Here’s where it is, Yale Hospital 코네티컷에서 가장 오래된 병원 Yale 은 거의 200년 전에 문을 열었습니다. 이곳이 바로 Yale 병원이 있는 곳입니다. Source-Yahoo 2/27/2025 Catherine Messier, USA TODAY NETWORK … Continued

What is Ozempic  오젬픽이란

posted in: Uncategorized | 0

What is Ozempic Ozempic (semaglutide) is a prescription medication primarily used to treat type 2 diabetes in adults. This FDA-approved medication helps manage blood sugar levels and reduces cardiovascular risks in patients with type 2 diabetes and heart disease. In patients with chronic … Continued

Yahoo News Measles outbreak FAQ: Do I need a vaccine booster? What do I do if I’ve been exposed? Here’s the latest about the highly contagious virus. 홍역 발병 FAQ: 백신 부스터가 필요한가요? 노출된 경우 어떻게 해야 하나요? 전염성이 매우 강한 바이러스에 대한 최신 소식입니다.

posted in: Uncategorized | 0

Measles outbreak FAQ: Do I need a vaccine booster? What do I do if I’ve been exposed? Here’s the latest about the highly contagious virus. Source Yahoo News 2/27/2025 홍역 발병 FAQ: 백신 부스터가 필요한가요? 노출된 경우 어떻게 해야 하나요? … Continued

Oral Infigratinib Therapy in Children with Achondroplasia 무형성증 아동의 경구 인피그라티닙 요법

posted in: Uncategorized | 0

Oral Infigratinib Therapy in Children with Achondroplasia Abstract Achondroplasia is a genetic skeletal condition that results in disproportionately short stature and medical complications throughout life. Infigratinib is an orally bioavailable FGFR1-3 selective tyrosine kinase inhibitor in development for achondroplasia.  The … Continued